Study participants were randomly assigned 2:1 to receive oral semaglutide 25mg (n=205) or placebo (n=102), as an adjunct to lifestyle intervention. The coprimary endpoints were the relative change in ...

Sade Last week Weeks at no. 1 Weeks on chart Epic/Legacy Greatest gainer this week Gains In Performance Week of May 3, 2025 click to see more ...